13 of the latest endocrinology guidelines/consensus, included in one article December guideline update

This article summarizes the recently released guidelines/consensus on endocrinology diseases at home and abroad for you to read and download
.

2023 ADA Standards of Medical Care for Diabetes (USA)

The Standards of Diabetes Medicine developed by the American Diabetes Association (ADA) is one of the important guidelines to guide the clinical practice of
diabetes physicians.
The 2023 ADA Diabetes Medical Diagnosis and Treatment Standards are released, mainly involving all current clinical practice recommendations of ADA, aiming to provide practical guidance for diabetes management, including a total of 17 parts
.

Literature link: https://guide.
medlive.
cn/guideline/27484

Expert Consensus on Clinical Issues Related to Insulin Resistance (2022 Edition) (China)

Insulin resistance is a common clinical phenomenon and is the pathophysiological basis
for chronic metabolism-related diseases such as type 2 diabetes, non-alcoholic fatty liver disease, atherosclerotic cardiovascular disease, and some rare and rare diseases.
In order to improve the understanding of insulin resistance among clinicians, the Diabetes Branch of the Chinese Medical Association organized experts to compile the Expert Consensus on Clinical Issues Related to Insulin Resistance (2022 Edition
).
This edition of the consensus interprets insulin resistance related issues in the form of questions and answers, aiming to improve clinicians' management of insulin resistance, improve clinical efficacy and patient outcomes
.

Literature link: https://guide.
medlive.
cn/guideline/27535

2022 JDS Consensus Statement: Drug Treatment Procedures for Patients with Type 2 Diabetes (Japan)

Up to 1/3 of the world's diabetics are concentrated in the Asian region, and between East and West, diabetes differs pathologically, including the degree of
obesity in affected patients.
This article mainly proposes the drug treatment process for patients with type 2 diabetes, prioritizing the selection of drugs that can appropriately address the pathology of diabetes in each patient, while weighing the available evidence for these drugs and the prescribing patterns
in clinical practice.
In the first step, the drug is selected according to the pathology of diabetes in each patient; The second step is to ensure the safety of patients; In the third step, measure the additional benefits of the drug for comorbidities; The fourth step is to consider the relevant background characteristics
of the patient when selecting the drug.

Literature link: https://guide.
medlive.
cn/guideline/27623

2022 ATA/ETA Consensus Statement: Management of Thyroid Eye Disease (US/Europe)

The clinical management of thyroid eye disease (TED) is challenging, and endocrinologists play a key role
in the diagnosis, initial management, and selection of patients requiring referral to specialist therapy at TED.
The American Thyroid Association (ATA) and the European Thyroid Association (ETA) provide consensus statements
on the management of thyroid eye disease.

Literature link: https://guide.
medlive.
cn/guideline/27461

2022 TES Clinical Practice Guidelines: Treatment of Hypercalcemia in Adult Malignancy (USA)

Hypercalcemia (HCM) is the most common metabolic complication of malignancy and its incidence may be decreasing
due to the use of effective chemotherapy drugs.
The American Endocrine Society (TES) has issued clinical guidelines to provide guidance and recommendations
for the treatment of hypercalcaemia in adult malignancies.

Literature link: https://guide.
medlive.
cn/guideline/27575

2022 EMAS Position Statement: Vitamin D and Menopausal Health (Europe)

There is growing evidence that vitamin D has a wide range of effects on tissues, and in addition to osteoporosis, vitamin D deficiency has been linked
to cardiovascular disease, diabetes, cancer, infections, and neurodegenerative diseases.
The European Association of Women and Men Menopause (EMAS) has published an expert consensus providing an evidence-based overview
of the role of vitamin D in the health of postmenopausal women based on observational and interventional studies.

Literature link: https://guide.
medlive.
cn/guideline/27624

Expert consensus on the clinical application of CXCR4 receptor imaging in the diagnosis of primary aldosteronism (2022) (China)

The classification and diagnosis of primary aldosteronism is the focus and difficulty of clinical work, and more and more clinical evidence shows that 68Ga-Pentixafor PET/CT nuclear imaging targeting CXCR4 can assist the classification
of primary aldosteronism.
Based on the latest research evidence at home and abroad, after in-depth discussion by a multidisciplinary expert group, a consensus was reached on the nuclide imaging method and interpretation of results, as well as its guidance and prognosis evaluation of treatment options
.
This consensus provides an important basis
for standardizing the imaging of 68Ga-Pentixafor PET/CT in China and improving the diagnosis and treatment level of primary aldosteronism in China.

Literature link: https://guide.
medlive.
cn/guideline/27459

2022 TES Clinical Practice Guidelines: Management of Patients at High Risk of Diabetes with Low Glycemia (USA)

Hypoglycemia is common in people with diabetes, especially those using insulin and sulfonylureas (SU).

The 2022 edition of the American Endocrine Society (TES) Practice Guidelines is an update to the 2009 American Endocrine Society guidelines for the assessment and management of hypoglycemia in adults, with the primary objective of reducing and preventing hypoglycemia
.

Literature link: https://guide.
medlive.
cn/guideline/27457

2022 ISPAD Clinical Practice Guidelines: Diagnosis and Management of Monogenic Diabetes in Children and Adolescents (International)

Monogenic diabetes is caused
by one or more defects in a single gene or chromosomal site.
The International Association of Childhood and Adolescent Diabetes (ISPAD) has published clinical practice guidelines that provide guidance on the diagnosis and management of monogenic diabetes in children and adolescents, and the recommendations cover the general situation of monogenic diabetes, neonatal diabetes, and diabetes in late adolescence
.

Literature link: https://guide.
medlive.
cn/guideline/27553

2022 ISPAD Clinical Practice Guidelines: Diabetes-Related and Other Complications in Children and Adolescents (International)

The International Association of Childhood and Adolescent Diabetes (ISPAD) has published clinical practice guidelines that provide updated recommendations
on diabetes-related and other complications in children and adolescents.
Guidelines revise recommendations for celiac disease (CD) screening and biopsy, including consideration of serology-based diagnostic approaches
.
Expanded the skin disorders section to include continuous glucose monitoring (CGM)-related and insulin pump-related skin problems
.
The section on bone health has been updated and general recommendations
for improving bone health in adolescents with type 1 diabetes have been made.

Literature link: https://guide.
medlive.
cn/guideline/27555

2022 ISPAD Clinical Practice Consensus Guidelines: Insulin Treatment for Children and Adolescents with Diabetes (International)

This article updates the insulin therapy section to include new pill and basal insulin formulations, detailed recommendations for the principles of intensive insulin regimens, an introduction to the role and rationale of insulin analogues, biosimilars, and diabetes technology devices in the treatment of pediatric diabetes, and presents key considerations for insulin accessibility and affordability
.

Literature link: https://guide.
medlive.
cn/guideline/27559

2022 ISPAD Clinical Practice Consensus Guidelines: Diabetes Technology – Blood Glucose Monitoring (International)

Self-monitoring of blood glucose plays a key role
in the management of insulin-treated children and adolescents with diabetes.
Since the publication of the 2018 guidelines, the field of blood glucose monitoring has changed, particularly when it comes to
continuous glucose monitoring (CGM) systems.
This article provides guidance on blood glucose monitoring
.

Literature link: https://guide.
medlive.
cn/guideline/27561

2022 ISPAD Clinical Practice Consensus Guidelines: Microvascular and Macrovascular Complications of Diabetes in Children and Adolescents (International)

Long-term vascular complications of diabetes include diabetic nephropathy (DKD), retinopathy, neuropathy, and macrovascular disease
.
This article provides guidance and recommendations
for the management of microvascular and macrovascular complications of diabetes mellitus in children and adolescents.

Literature link: https://guide.
medlive.
cn/guideline/27562

Disclaimer: This platform is designed to deliver more medical information
to healthcare professionals.
The content published on this platform cannot replace professional medical guidance in any way, nor should it be regarded as diagnosis and treatment advice
.
If such information is used for purposes other than understanding medical information, this platform does not assume relevant responsibilities
.
The content published by this platform does not mean that it agrees with its description and views
.
If copyright issues are involved, please contact us and we will deal with
it as soon as possible.